Marcus Wilson is President of HealthCore, Anthem’s wholly-owned research and evidence development business. For more than 20 years, he has been extensively involved in efforts to effectively integrate real-world data from multiple sources to create a complete view of the individual’s experience within the healthcare system and to utilize this view and the surrounding real-world data environments to accelerate healthcare evidence development, innovation and to facilitate clinical decision support.
Dr. Wilson is active on a number of boards and national committees including serving as chair of the Innovations in Medical Evidence Development (IMEDS) Steering Committee, Reagan-Udall Foundation for the FDA; member of the FDA Sentinel Initiative Planning Board; Board of Directors for the Center for Medical Technology Policy (CMTP); and a member of the Dean’s Roundtable, College of Science, Virginia Tech. Dr. Wilson is a past member of a number boards and committees including the Planning Committee for the National Academy of Medicine’s recent Real-World Evidence Workshop Series conducted for FDA in response to the 21st Century Cures legislation, chair of the Joint Research Committee for the Academy of Managed Care Pharmacy (AMCP) & the AMCP Foundation, the Board of Directors for the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) and member of the Board of Directors for the eHealth Initiative.
Dr. Wilson received his Bachelor of Science in Biochemistry from Virginia Tech and his Doctor of Pharmacy degree from the Medical College of Virginia. He completed a residency in Family Medicine at the Medical University of South Carolina. Prior to co-founding HealthCore in 1996, Dr. Wilson spent seven years within an integrated delivery system owned by BCBS of Delaware where he oversaw the physician and patient clinical decision support, pharmacy policy and clinical trials programs as well as a faculty member at the Philadelphia College of Pharmacy.